Project Grant R35GM157100

Award Date 5/1/25
Completion Date 3/31/30
Dollars Obligated $400K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This Project Grant award for $145,598, provided by the National Science Foundation (NSF) under the Mathematical and Physical Sciences (CFDA 47.049) program, supports the development of peptide-based, stimuli-responsive biomaterials for wound healing and drug delivery applications. The principal investigator at Baylor University will design three classes of self-healing, antimicrobial hydrogels that change stiffness in response to changes in redox state and pH. This research aims to generate...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports two key research efforts at Baylor University: Project 1 aims to expand the use of NMR-guided directed evolution techniques to develop new metalloproteins and catalysts for practical applications such as pesticide/chemical weapons remediation, DNA hydrolysis, and phenol oxidation. The $235,959 award will fund research to...
This federal Project Grant award, with ID R35GM155449, was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award, totaling $1,139,265.00, is for the project "Leveraging Cell-Instructive Hydrogels to Understand Microenvironmental Impact on Wound Healing Processes" at Purdue University. The key products and services to be delivered under this grant include the development of in vitro...
This $351,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports a 5-year research project at the University of Miami to engineer chondroitin sulfate (CS) biomaterials that can reprogram inflammatory immune states and promote tissue repair. The goal is to investigate the use of nanoscale and microscale CS biomaterials to resolve excess inflammatory cytokine activity and shift...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $440,000.00 in funding to Baylor College of Medicine to conduct research on biopolymers for intestinal healing and immune modulation to treat inflammatory bowel disease. The award has a performance period from January 15, 2025 to January 14, 2027. As a prominent research university and frequent federal contractor, Baylor College of Medicine has...
This federal Project Grant award of $305,426 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The grant is funding a research project at Worcester Polytechnic Institute (WPI) and the University of Massachusetts Amherst to develop a multiscale theory and experimental framework for understanding tissue fluidity and flow patterns in partial epithelial-mesenchymal transition (PEMT) cell monolayers....
The National Institute of General Medical Sciences (NIGMS) awarded a $368,235 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of New Hampshire (UNH) to establish an integrated bioengineering framework for understanding how the synergistic effects of soluble and bound factors in biomaterials influence cell signaling and modulate cell function to promote chronic wound angiogenesis and healing. The project aims to develop an in vitro microfluidic...
This federal Project Grant award of $440,454 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support a research project focused on epithelial cell mechanobiology in mechanically heterogeneous microenvironments. The primary objectives are to study how epithelial cells sense and respond to extracellular wounds, whether epithelial migration can occur with lower forces by modifying extracellular matrix...
This Project Grant award for $1,237,500 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports a 5-year research project led by Trustees of Boston University to investigate mechanisms for enhancing parenchymal cell self-renewal and improving adult wound healing outcomes. The key initiatives under this grant include: 1) dissecting mitotic and anti-mitotic growth factor signaling...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $400,000.00 to support research aimed at elucidating the molecular mechanisms of cytokine activation and the spatiotemporal regulation of innate immunity. The research will focus on understanding how macromolecular signaling complexes known as inflammasomes are assembled and activated, with the goal of shedding light...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $400,000.00 to Baylor College of Medicine to develop and optimize bioengineered polymers with tunable properties to modulate inflammatory responses in the tissue microenvironment, thereby enhancing tissue repair and regeneration across a spectrum of wound types. The research aims to systematically investigate how biopolymers' chemical and mechanical properties influence inflammatory response and tissue healing, with the goal of engineering biopolymers that can either mitigate excessive inflammation in chronic wounds or enhance necessary inflammatory responses in normal wound healing. The project will integrate immunology with polymer surface chemistry and employ 3D fabrication strategies to modify the surface charges of biopolymers and optimize elasticity and porosity, with the award period running from May 1, 2025 to March 31, 2030.

Generated 5/13/25, 3:30 AM